MX2024008333A - Compuestos para tratamiento de pérdida de cabello. - Google Patents

Compuestos para tratamiento de pérdida de cabello.

Info

Publication number
MX2024008333A
MX2024008333A MX2024008333A MX2024008333A MX2024008333A MX 2024008333 A MX2024008333 A MX 2024008333A MX 2024008333 A MX2024008333 A MX 2024008333A MX 2024008333 A MX2024008333 A MX 2024008333A MX 2024008333 A MX2024008333 A MX 2024008333A
Authority
MX
Mexico
Prior art keywords
compounds
hair loss
loss treatment
treatment
mammal
Prior art date
Application number
MX2024008333A
Other languages
English (en)
Spanish (es)
Inventor
Daniel Lui Sun
Daniel Walter Gil
Original Assignee
Pelage Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pelage Pharmaceuticals Inc filed Critical Pelage Pharmaceuticals Inc
Publication of MX2024008333A publication Critical patent/MX2024008333A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
MX2024008333A 2021-12-29 2022-12-21 Compuestos para tratamiento de pérdida de cabello. MX2024008333A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163294775P 2021-12-29 2021-12-29
PCT/US2022/082185 WO2023129854A1 (en) 2021-12-29 2022-12-21 Compounds for treatment of hair loss

Publications (1)

Publication Number Publication Date
MX2024008333A true MX2024008333A (es) 2024-08-30

Family

ID=85157456

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024008333A MX2024008333A (es) 2021-12-29 2022-12-21 Compuestos para tratamiento de pérdida de cabello.

Country Status (12)

Country Link
US (1) US20250163045A1 (enExample)
EP (1) EP4457226A1 (enExample)
JP (1) JP2025502850A (enExample)
KR (1) KR20240129011A (enExample)
CN (1) CN118829641A (enExample)
AR (1) AR128100A1 (enExample)
AU (1) AU2022425460A1 (enExample)
CA (1) CA3244825A1 (enExample)
IL (1) IL314007A (enExample)
MX (1) MX2024008333A (enExample)
TW (1) TW202333692A (enExample)
WO (1) WO2023129854A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12649736B2 (en) 2019-12-20 2026-06-09 The Regents Of The University Of California Synthesis of compounds to promote hair growth
EP4172159A4 (en) 2020-06-30 2024-01-10 The Regents of the University of California Compositions and methods for modulating hair growth
CN121005682A (zh) * 2024-05-24 2025-11-25 上海医药工业研究院有限公司 一种2-苯基-吡咯类化合物、其制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL321754A (en) 2017-06-30 2025-08-01 Univ California Compositions and methods for modulating hair growth
MX2021008089A (es) * 2019-01-02 2021-08-05 Univ California Composiciones y metodos para modular el crecimiento del cabello.
EP4172159A4 (en) * 2020-06-30 2024-01-10 The Regents of the University of California Compositions and methods for modulating hair growth
EP4172158A4 (en) * 2020-06-30 2024-01-10 The Regents of the University of California Compositions and methods for modulating hair growth

Also Published As

Publication number Publication date
CN118829641A (zh) 2024-10-22
CA3244825A1 (en) 2023-07-06
WO2023129854A1 (en) 2023-07-06
IL314007A (en) 2024-08-01
AR128100A1 (es) 2024-03-27
TW202333692A (zh) 2023-09-01
KR20240129011A (ko) 2024-08-27
EP4457226A1 (en) 2024-11-06
US20250163045A1 (en) 2025-05-22
AU2022425460A1 (en) 2024-07-18
JP2025502850A (ja) 2025-01-28

Similar Documents

Publication Publication Date Title
CY1124239T1 (el) Ενωσεις αμινο-τριαζολοπυριδινης και χρηση αυτων στην αγωγη του καρκινου
MX2024014142A (es) Novedosos inhibidores de molecula peque?a de factores de transcripcion tead
CL2020002146A1 (es) Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer.
EA201490864A1 (ru) Производные (4-фенилимидазол-2-ил)этиламина в качестве модуляторов натриевых каналов
CL2021003098A1 (es) Compuestos inmunomoduladores diméricos contra mecanismos basados en cereblon (divisional de la solicitud no. 202100061)
EA201490647A1 (ru) Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции
MX389965B (es) Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos
CY1126039T1 (el) Ενωσεις και συνθεσεις ουριας ως αναστολεις της ατρ-ασης smarca2/brm
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
PY1923494A (es) Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida
PE20191557A1 (es) Compuestos de pirimidinil-pyridiloxi-naftil y metodos para tratar enfermedades y trastornos relacionados con ire1
CO2021002977A2 (es) Dimetilaminoazetidinaminas como inhibidores de jak
MX2022013856A (es) Moduladores htt para tratar la enfermedad de huntington.
CO2021002976A2 (es) Amidas heterocíclicas de 5 a 7 miembros como inhibidores de jak
JOP20200024A1 (ar) مركبات ثنائي هيدروكساديازينون
EA201000098A1 (ru) Производные хиназолинамида
SA521430330B1 (ar) Eed و rc2 مشتقات آزولوبيريدين كبيرة الحلقة كمعدلات
MX2022014925A (es) Moduladores de il-17a.
PE20211548A1 (es) Compuesto de triazina y su uso para fines medicos
UY36257A (es) “compuestos de imidazopiridazina”.
ECSP22083772A (es) Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso
MX2019013562A (es) Compuestos de anilina heteroaromatica o fusionados para el tratamiento de trastornos dermicos.
AR128100A1 (es) Compuestos para el tratamiento de la pérdida del cabello
EA202190308A1 (ru) Применение пролекарств рилузола для лечения болезни альцгеймера
EP4297765A4 (en) COMPOSITION FOR THE TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS